Evidence map›Paper›PMID 8572693›Full record

ArticleApplied and environmental microbiology1996

Purification and characterization of two arabinofuranosidases from solid-state cultures of the fungus Penicillium capsulatum.

E X Filho, J Puls, M P Coughlan

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Alpha-L-arabinofuranosidases: the potential applications in biotechnology.Journal of industrial microbiology & biotechnology · 2006
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

E X FilhoDepartamento de Biologia Celular, Universidade de Brasílla, DF, Brazil.
J Puls
M P Coughlan
Universidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two arabinofuranosidases, termed Ara I and Ara II, from solid-state cultures of Penicillium capsulatum were purified to apparent homogeneity as judged by electrophoresis and isoelectric focusing. Each enzyme is a single subunit glycoprotein, and they have M(r)s and pIs of 64,500 and 4.15 (Ara I) and 62,700 and 4.54 (Ara II), respectively. Ara I is most active at pH 4.0 and 60 degrees C, while Ara II exhibits optimal activity at pH 4.0 and 55 degrees C. Ara I is the more thermostable, with its half-life at 70 degrees C and pH 4.0 being 17.5 min. By contrast, the half-life of Ara II is only 9 min at 60 degrees C and pH 4.0. Ara I has the lower Km and higher catalytic constant values with p-nitrophenyl-alpha-L-arabinofuranoside being used as the substrate. Arabinose, a competitive inhibitor (Ki, 16.4 mM) of Ara II, has no effect on Ara I activity at concentrations of up to 40 mM. Each enzyme catalyzes the release of arabinose from pectin, araban, and certain arabinose-containing xylans. The last activity is enhanced by pretreatment of the relevant substrates with xylanase, ferulic acid esterase, or combinations of these enzymes. Thus, arabinoxylooligosaccharides in which arabinose is the sole side chain substituent appear to be the preferred substrates. On the basis of the evidence cited above, each enzyme has been classified as an alpha-L-arabinofuranoside arabinofuranohydrolase (EC 3.2.1.79).

Indexed as

ArabinoseChromatography, LiquidEnzyme StabilityGlycoside HydrolasesHydrolysisIsoelectric PointKineticsMolecular WeightPenicilliumSubstrate SpecificityXylansalpha-N-arabinofuranosidaseArabinoseGlycoside HydrolasesXylans

Identifiers

PMID8572693
PMCPMC167784
OpenAlexW2112999830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.